The heat is on payers to identify which brands offer the best value, and ...
Four pharmaceutical and biotech companies—Merck, GlaxoSmithKline, Pfizer and Sanofi—have the most in-person meetings with ...
For years, managed-care organizations have tried to reduce drug costs through generic substitution, denials, ...
SURE, FORMULARY TIERS ARE IMPORTANT. But they are only part of the equation. By ...